This pilot study investigates the sero-conversion rates of hepatitis B vaccinated individuals. The study was completed at a community clinic in Laguna Beach, California, where 100 predominantly white male individuals who were all vaccinated for hepatitis B were tested for sero-conversion. The purpose of this pilot study was to examine if the hepatitis B sero-conversion rates in a small sample of subjects reflected that of the published data, regardless of HIV status, after a hepatitis B vaccination series was completed, while following strict vaccine protocols. The theoretical framework for this study is focused on evidence-based practice, which drives practice to integrate new research into clinical protocols. Two frameworks were implemented first the Academic Center for Evidenced-based practice (ACE) Star Model of Knowledge Transformation, and the Awareness-to-Adherence model; both of which will be applied in order for practitioners to adopt immunization recommendations. This pilot study was conducted through a non-experimental, correlational cross sectional design. This design was used to evaluate the sero-conversion rates of a subject receiving a primary vaccine series of hepatitis B and who was hepatitis B naïve. Manufacturer published rates of sero-conversion are between 80% and 95%, depending upon the population studied. The results of the study demonstrated that sero-conversion rates were similar, but not as high as reported by the manufactures of the Hepatitis B vaccines. The data demonstrated that in HIV negative men (n=50), who received the 3 dose regimen, 78.6% sero-converted, and the sero-conversion rates of the HIV positive men was (n=48) 77%. This data is important with regard to current vaccine practice in all individuals who are vaccinated against hepatitis B. This includes healthcare workers, the immune-compromised and high-risk general populat
|Commitee:||Boller, Janet, Emanuele, Donna|
|School:||Western University of Health Sciences|
|Department:||College of Graduate Nursing|
|School Location:||United States -- California|
|Source:||DAI-B 75/08(E), Dissertation Abstracts International|
|Keywords:||HIV, Hepatitis b, Seroconversion, Vaccination|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be